| Individual variations of platelet inhibition after loading doses of clopidogrel P Järemo, TL Lindahl, SG Fransson, A Richter Journal of internal medicine 252 (3), 233-238, 2002 | 452 | 2002 |
| Chicken antibodies: taking advantage of evolution—a review A Larsson, ROSM BÅLÖW, TL LINDAHL, PERO FORSBERG Poultry science 72 (10), 1807-1812, 1993 | 384 | 1993 |
| Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays A Hillarp, F Baghaei, IF Blixter, KM Gustafsson, L Stigendal, ... Journal of Thrombosis and Haemostasis 9 (1), 133-139, 2011 | 356 | 2011 |
| Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays TL Lindahl, F Baghaei, IF Blixter, KM Gustafsson, L Stigendal, ... Thrombosis and haemostasis 105 (02), 371-378, 2011 | 333 | 2011 |
| Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies T Lindahl, G Klein, BM Reedman, B Johansson, S Singh International journal of cancer 13 (6), 764-772, 1974 | 310 | 1974 |
| Exclusion of deep venous thrombosis with D-dimer testing F van der Graaf, H van den Borne, M van der Kolk, PJ de Wild, ... Thrombosis and haemostasis 83 (02), 191-198, 2000 | 292 | 2000 |
| Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma B Wiman, Å Almquist, O Sigurdardottir, T Lindahl FEBS letters 242 (1), 125-128, 1988 | 219 | 1988 |
| Stability of plasminogen activator inhibitor 1 (PAI-1) TL Lindahl, O Sigurdardottir, B Wiman Thrombosis and haemostasis 62 (06), 748-751, 1989 | 201 | 1989 |
| The use of platelet density and volume measurements to estimate the severity of pre‐eclampsia P Järemo, TL Lindahl, C Lennmarken, H Forsgren European journal of clinical investigation 30 (12), 1113-1118, 2000 | 184 | 2000 |
| Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces KM Hansson, S Tosatti, J Isaksson, J Wetterö, M Textor, TL Lindahl, ... Biomaterials 26 (8), 861-872, 2005 | 172 | 2005 |
| Chicken antibodies: a tool to avoid interference by complement activation in ELISA A Larsson, PE Wejåker, PO Forsberg, T Lindahl Journal of immunological methods 156 (1), 79-83, 1992 | 157 | 1992 |
| The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator TL Lindahl, PI Ohlsson, B Wiman Biochemical Journal 265 (1), 109-113, 1990 | 142 | 1990 |
| Comparison of surface plasmon resonance and quartz crystal microbalance in the study of whole blood and plasma coagulation TP Vikinge, KM Hansson, P Sandström, B Liedberg, TL Lindahl, ... Biosensors and Bioelectronics 15 (11-12), 605-613, 2000 | 141 | 2000 |
| Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays A Hillarp, KM Gustafsson, L Faxälv, K Strandberg, F Baghaei, IF Blixter, ... Journal of Thrombosis and Haemostasis 12 (9), 1545-1553, 2014 | 132 | 2014 |
| Cystatin C and NT‐proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in … U Alehagen, U Dahlström, TL Lindahl European journal of heart failure 11 (4), 354-360, 2009 | 123 | 2009 |
| Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation TL Lindahl, R Festin, A Larsson Thrombosis and haemostasis 68 (08), 221-225, 1992 | 119 | 1992 |
| Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia R Boij, J Svensson, K Nilsson‐Ekdahl, K Sandholm, TL Lindahl, ... American journal of reproductive immunology 68 (3), 258-270, 2012 | 118 | 2012 |
| Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure U Alehagen, U Dahlström, TL Lindahl Thrombosis and haemostasis 92 (12), 1250-1258, 2004 | 107 | 2004 |
| Platelet function determined by flow cytometry: new perspectives? S Ramström, AL Södergren, N Tynngård, TL Lindahl Seminars in Thrombosis and Hemostasis 42 (03), 268-281, 2016 | 102 | 2016 |
| Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery K Wåhlander, G Larson, TL Lindahl, C Andersson, L Frison, D Gustafsson, ... Thrombosis and haemostasis 87 (04), 580-585, 2002 | 102 | 2002 |
